Events & conferences in the Life Sciences industry
Below you find a list of upcoming events in the Life Sciences industry. We will be attending all events which are flagged with the Biotechgate / Venture Valuation logo.
If you are participating the conference and want to learn more, please contact us to schedule a meeting ››
Biotechgate Digital Partnering
Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.
Swiss Biotech Day 2021
The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and is a fixed date in the community’s calendar. While the event could not take place in 2020 due to the worldwide COVID-19 pandemic, we plan to bring the Swiss Biotech Day back on stage on September 7, 2021. What to expect: · Meet senior experts from the life science industry from across Europe · Exhibition throughout the day · Delegations from various countries · Swiss Biotech Success Stories Awards · Innovative biotech start-ups and medium-sized biotech companies · Thematically focused panel discussions · Pre-scheduled one-to-one partnering meetings
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
Life Sciences Baltics
Life Sciences Baltics is the only and finest Baltics’ life sciences forum gathering global biotechnology, pharmaceutical and medical devices leaders. Forum provides a unique programme that features a variety of opportunities to get insights and seek process of life sciences through the conference, plenary and educational sessions, potential one-on-one meetings and scientific posters area. Discover Lithuania and the Baltics as a potential gateway to emerging markets in a global life sciences’ landscape.
BioPharm America™ 2021
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
Online & Oxford UK
BioForward is a full-day event designed to be a practical, ‘one-stop-shop’ that provides leaders of growing Life Sciences companies with the knowledge, skills, connectivity, and services necessary to achieve sustainable commercial success.
BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+773). 34% of our delegates came from outside of Spain. Since 1999, the Spanish Bioindustry Association (AseBio) worked to achieve positive political and economic changes that promote and boost the development of the Spanish biotechnology industry. In order to do this, AseBio works closely with regional, national and European legislative bodies, as well as with all those social organisations that are committed to using biotechnology to improve citizens’ quality of life, environmental sustainability, economic development and skilled job creation.
HealthTech Innovation Days
The HealthTech Innovation Days demonstrates that access to innovative care for all depends on the right funding and partnership in-between actors in health and finance. This event organized by HealthTech For Care, an endowment fund launched by France Biotech, and co-organised with EIT Health, and in collaboration with BIO Deutschland, BioWin , CEBR, Flanders.bio,LifeSci , Irefi, Assobiotec, P-Bio, SwissBiotech & Sweden Bio will accelerate patient access to healthcare solutions and contribute to building a stronger ecosystem. This event is open to many attendees of the healthcare ecosystem.
8th Annual HealthTech Investment Forum
The main programme for the 8th Annual HTIF is spread throughout 2 days (5th-6th of October) and will include HealthTech Innovation Day, focusing on Investment & Partnership in MedTech and Digital Health, and Managing Covid-19 Pandemic & Future Global Threats Day, which will include keynotes covering global supply chain and diagnostics. The two days will feature more than 12 hours of high-level speeches, panel discussions and spotlight showcases by leading industry corporates. In addition, there is a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and are seeking investment and partnering opportunities. We anticipate 300+ delegates drawn from Digital Health, MedTech/Device companies, banks, investors and advisors.
New York City USA
BioFuture is a new two-day life science summit that features 80 company presentations, plenary sessions, workshops, and one-to-one partnering with over 550 attendees, including biopharma, life science, digital medicine, and key advisors.
21st Annual Biotech in Europe Forum
Back for its 21st Annual Edition, this global bio-pharma industry event will address through its programme the main challenges for 2021 in investment, partnering and alliance management and prospects for 2022. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. The main programme for the 21st Annual BEF is spread throughout 2 days (7th-8th of October) and will include BioCapital & Investment Day and Bio-Pharma Partnering & Therapeutics Day. The two days will feature more than 15 hours of high-level speeches, panel discussions and spotlight showcases by leading industry corporates. In addition, there is a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of Spotlight presentations, which will be delivered live as part of the main programme, other presentations will be added under company showcases and will be available on demand. We anticipate 650+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, bankers and advisors. Meetings will take place from the 4th to 8th of October. Moreover, the system will be open for 12 hours a day and we expect 1500+ meetings completed over 5 days. The conference will be held in Central European Time Zone.
BIO Investor Forum Digital
The BIO Investor Forum Digital is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.
BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
Pharma-Biotech Product & Company Valuation with Dr. P Frei
Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
GIANT Health Event
The GIANT (Global Innovation and New Technology) Health Event is an unmissable innovation festival with over 25 conferences, 450 speakers, immersive workshops, and Beanstalks (a global startup competition for prizes). Our vision is to improve the health and well-being of people around the world, by promoting healthcare innovation and supporting health-tech entrepreneurs. In 2021, we will be holding two events aimed at creating opportunities to connect people who would not have crossed paths otherwise.
BioFIT - Fostering Innovation & Transfer
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
MedFIT - Fostering Innovation in MedTech
With 700 international participants from 25+ countries, MedFIT is your opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access.
Hong Kong China
BIOHK2021 is an international convention organized by HKBIO that aims to provide a global platform for exploring the potential and limitless biotech opportunities sprouting in Hong Kong and allow networking between leading industry practitioners from around the globe. BIOHK2021 is comprised of three events - the Expo, Conference & Roadshow, and One2One Partnering. All three will be held simultaneously over a period of 4 days in Hong Kong.